DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalsotra, A.
Right arrow Articles by Strobel, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalsotra, A.
Right arrow Articles by Strobel, H. W.

Vol. 30, Issue 9, 1022-1028, September 2002

Sexual Dimorphism and Tissue Specificity in the Expression of CYP4F Forms in Sprague Dawley Rats

Auinash Kalsotra, Sayeepriyadarshini Anakk, Christopher L. Boehme, and Henry W. Strobel

Department of Biochemistry and Molecular Biology, the University of Texas Medical School of Houston, Houston, Texas

The cytochromes P450 belong to a superfamily of enzymes involved in a diverse array of endobiotic and xenobiotic metabolic pathways. Several members of a novel family of cytochrome P450 (CYP4F), which specifically mediate leukotriene B4 omega -hydroxylation, have now been identified in various species including rat, mouse, and human. In rats, the CYP4F family consists of four related genes, CYP4F1, CYP4F4, CYP4F5, and CYP4F6. Here we report development of fluorescent real-time quantitative polymerase chain reaction assays (TaqMan), which allow us to carry out specific quantitation of mRNA expression of all four members of this subfamily. Since no inducers for the CYP4F family are known to date, we validated these assays using clofibrate, a known suppressor of rat CYP4Fs. Additionally, Northern blot hybridization was carried out to validate these assays. Using this approach, we demonstrate quantitatively, for the first time, that each of the rat CYP4Fs is expressed in a tissue- and sex-dependent manner showing a significantly higher expression in females vis-à-vis males. Western blot analysis using a CYP4F polyclonal antibody also shows a considerably higher protein expression in female liver, kidneys, and lungs when compared with male rats. Furthermore, we observe a significant decrease in the CYP4F1, CYP4F4, and CYP4F6 message in kidneys and liver of ovariectomized rats when compared with control females. This loss of expression is partially restored by estrogen treatment in both tissues, suggesting a role of estrogen in regulating CYP4F expression.

Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
S. E.-M. Peychal, A. Bilger, H. C. Pitot, and N. R. Drinkwater
Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17
Carcinogenesis, May 1, 2009; 30(5): 879 - 885.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
B. N. M. Zordoky, M. E. Aboutabl, and A. O. S. El-Kadi
Modulation of Cytochrome P450 Gene Expression and Arachidonic Acid Metabolism during Isoproterenol-Induced Cardiac Hypertrophy in Rats
Drug Metab. Dispos., November 1, 2008; 36(11): 2277 - 2286.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. T. Williams, M. Leyk, S. A. Wrighton, P. J. A. Davies, D. S. Loose, G. L. Shipley, and H. W. Strobel
Estrogen Regulation of the Cytochrome P450 3A Subfamily in Humans
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 728 - 735.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. Nisar, C. S. Lane, A. F. Wilderspin, K. J. Welham, W. J. Griffiths, and L. H. Patterson
A PROTEOMIC APPROACH TO THE IDENTIFICATION OF CYTOCHROME P450 ISOFORMS IN MALE AND FEMALE RAT LIVER BY NANOSCALE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-TANDEM MASS SPECTROMETRY
Drug Metab. Dispos., April 1, 2004; 32(4): 382 - 386.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
F. Xu, J. R. Falck, P. R. Ortiz de Montellano, and D. L. Kroetz
Catalytic Activity and Isoform-Specific Inhibition of Rat Cytochrome P450 4F Enzymes
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 887 - 895.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
M.-H. Wang, J. Wang, H.-H. Chang, B. A. Zand, M. Jiang, A. Nasjletti, and M. Laniado-Schwartzman
Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats
Am J Physiol Renal Physiol, August 1, 2003; 285(2): F295 - F302.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Anakk, C. Y. Ku, M. Vore, and H. W. Strobel
Insights into Gender Bias: Rat Cytochrome P450 3A9
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 703 - 709.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.